论文部分内容阅读
目的:探讨压缩雾化吸入布地奈德和特布他林联合溶液治疗婴幼儿喘息性疾病的疗效。方法:将96例患儿随机分为观察组和对照组,每组各48例。两组患儿综合治疗方法相同,观察组在此基础上压缩雾化吸入布地奈德和特布他林,对照组予静脉滴注糖皮质激素和氨茶碱。对两组患儿的有效率及治疗后咳嗽、喘息、哮鸣音的消失时间及住院时间进行比较,并进行统计学处理。结果:两组显效率、总有效率及咳嗽、喘息、哮鸣音的消失时间及住院时间等方面比较差异有统计学意义(P<0.01或P<0.05),观察组明显优于对照组。结论:压缩雾化吸入布地奈德和特布他林联合溶液治疗婴幼儿喘息性疾病疗效确切,操作简单,安全实用,可缩短病程,值得临床推广应用。
Objective: To investigate the curative effect of compressed inhalation of budesonide and terbutaline combined solution on infantile asthmatic disease. Methods: 96 cases of children were randomly divided into observation group and control group, 48 cases in each group. The two groups of children with the same method of treatment, the observation group on the basis of compression inhalation of budesonide and terbutaline, the control group intravenous glucocorticoid and aminophylline. The effectiveness of the two groups of children and after treatment cough, wheezing, wheezing disappearance of time and hospital stay were compared and statistically analyzed. Results: There were significant differences between the two groups in apparent efficiency, total effective rate, cough, wheezing, disappearance time of wheeze and length of hospital stay (P <0.01 or P <0.05), and the observation group was significantly better than the control group. Conclusion: Compression atomization inhalation of budesonide and terbutaline combined solution of infantile asthma is effective, simple, safe and practical, can shorten the course of disease, it is worthy of clinical application.